Loki Therapeutics today announced the publications of research in the journal, “Science Translational Medicine”, demonstrating the potential of AWAKE-LM-TT in the treatment of pancreatic cancer. AWAKE-LM-TT, which was developed by Claudia Gravekamp, Ph.D., Loki’s Co-Founder and Associated Professor of Microbiology & Immunology at Albert Einstein School of Medicine, capitalizes on the childhood vaccination for tetanus…
БҰЛ МАҚАЛАДАН НЕ АЛУ КЕРЕК:
- Loki Therapeutics today announced the publications of research in the journal, “Science Translational Medicine”, demonstrating the potential of AWAKE-LM-TT in the treatment of pancreatic cancer.
- Immunology at Albert Einstein School of Medicine, capitalizes on the childhood vaccination for tetanus….
- eTurboNews мақалалар тек жазылушыларға арналған.